• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Lilly reports encouraging trial results for its next-gen GLP-1 shot

Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current bestseller, tirzepatide.

J. Edward Moreno
Author: J. Edward Moreno

Source: Sherwood News.

Written by

J. Edward Moreno

in

Business
←WATCH: Best friends of 50 years go viral after one shares cancer journey
21 Essential Books That Fiercely Celebrate Black Womanhood→

More posts

  • Clarence Carter Dies: ‘Slip Away’, ‘Patches’ Singer Was 90

  • Justice Department sues DC authorities over efforts to discipline Jeff Clark, Ed Martin

  • Taiwan emerges as major tension in Trump-Xi summit

  • Israel to sue NY Times over Palestinian prisoner rape allegations

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube